NR2B-Selective N-Methyl-d-aspartate Antagonists:  Synthesis and Evaluation of 5-Substituted Benzimidazoles

This article is cited by 50 publications.

1. Lynnea D. Harris, Michael C. Regan, Scott J. Myers, Kelsey A. Nocilla, Nicholas S. Akins, Yesim A. Tahirovic, Lawrence J. Wilson, Ray Dingledine, Hiro Furukawa, Stephen F. Traynelis, Dennis C. Liotta. Novel GluN2B-Selective NMDA Receptor Negative Allosteric Modulator Possesses Intrinsic Analgesic Properties and Enhances Analgesia of Morphine in a Rodent Tail Flick Pain Model. ACS Chemical Neuroscience 2023, 14 (5) , 917-935. https://doi.org/10.1021/acschemneuro.2c00779
2. Patrice Marchand, Javier Becerril-Ortega, Laetitia Mony, Cédric Bouteiller, Pierre Paoletti, Olivier Nicole, Louisa Barré, Alain Buisson, and Cécile Perrio . Confocal Microscopy Imaging of NR2B-Containing NMDA Receptors Based on Fluorescent Ifenprodil-Like Conjugates. Bioconjugate Chemistry 2012, 23 (1) , 21-26. https://doi.org/10.1021/bc100571g
3. Yesim A. Tahirovic, Matthew Geballe, Ewa Gruszecka-Kowalik, Scott J. Myers, Polina Lyuboslavsky, Phuong Le, Adam French, Hasan Irier, Woo-baeg Choi, Keith Easterling, Hongjie Yuan, Lawrence J. Wilson, Robert Kotloski, James O. McNamara, Raymond Dingledine, Dennis C. Liotta, Stephen F. Traynelis and James P. Snyder . Enantiomeric Propanolamines as selective N-Methyl-d-aspartate 2B Receptor Antagonists. Journal of Medicinal Chemistry 2008, 51 (18) , 5506-5521. https://doi.org/10.1021/jm8002153
4. Igor Shamovsky, Stephen Connolly, Laurent David, Svetlana Ivanova, Bo Nordén, Brian Springthorpe and Klaus Urbahns . Overcoming Undesirable hERG Potency of Chemokine Receptor Antagonists Using Baseline Lipophilicity Relationships. Journal of Medicinal Chemistry 2008, 51 (5) , 1162-1178. https://doi.org/10.1021/jm070543k
5. István Borza,, Éva Bozó,, Gizella Barta-Szalai,, Csilla Kiss,, Gábor Tárkányi,, Ádám Demeter,, Tamás Gáti,, Viktor Háda,, Sándor Kolok,, Anikó Gere,, László Fodor,, József Nagy,, Kornél Galgóczy,, Ildikó Magdó,, Béla Ágai,, József Fetter,, Ferenc Bertha,, György M. Keserü,, Csilla Horváth,, Sándor Farkas,, István Greiner, and, György Domány. Selective NR1/2B N-Methyl-d-aspartate Receptor Antagonists among Indole-2-carboxamides and Benzimidazole-2-carboxamides. Journal of Medicinal Chemistry 2007, 50 (5) , 901-914. https://doi.org/10.1021/jm060420k
6. Nigel J. Liverton,, Rodney A. Bednar,, Bohumil Bednar,, John W. Butcher,, Christopher F. Claiborne,, David A. Claremon,, Michael Cunningham,, Anthony G. DiLella,, Stanley L. Gaul,, Brian E. Libby,, Elizabeth A. Lyle,, Joseph J. Lynch,, John A. McCauley,, Scott D. Mosser,, Kevin T. Nguyen,, Gary L. Stump,, Hong Sun,, Hao Wang,, James Yergey, and, Kenneth S. Koblan. Identification and Characterization of 4-Methylbenzyl 4-[(Pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an Orally Bioavailable, Brain Penetrant NR2B Selective N-Methyl-d-Aspartate Receptor Antagonist. Journal of Medicinal Chemistry 2007, 50 (4) , 807-819. https://doi.org/10.1021/jm060983w
7. Craig Jamieson,, Elizabeth M. Moir,, Zoran Rankovic, and, Grant Wishart. Medicinal Chemistry of hERG Optimizations:  Highlights and Hang-Ups. Journal of Medicinal Chemistry 2006, 49 (17) , 5029-5046. https://doi.org/10.1021/jm060379l
8. Roland E. Dolle. Comprehensive Survey of Combinatorial Library Synthesis:  2004. Journal of Combinatorial Chemistry 2005, 7 (6) , 739-798. https://doi.org/10.1021/cc050082t
9. Zhenxing Wu, Jike Wang, Hongyan Du, Dejun Jiang, Yu Kang, Dan Li, Peichen Pan, Yafeng Deng, Dongsheng Cao, Chang-Yu Hsieh, Tingjun Hou. Chemistry-intuitive explanation of graph neural networks for molecular property prediction with substructure masking. Nature Communications 2023, 14 (1) https://doi.org/10.1038/s41467-023-38192-3
10. Vinod Ugale, Ashish Dhote, Rushikesh Narwade, Saurabh Khadse, P. Narayana Reddy, Atul Shirkhedkar. GluN2B/N-methyl-D-aspartate Receptor Antagonists: Advances in Design, Synthesis, and Pharmacological Evaluation Studies. CNS & Neurological Disorders - Drug Targets 2021, 20 (9) , 822-862. https://doi.org/10.2174/1871527320666210309141627
11. Scott J. Myers, Kamalesh P. Ruppa, Lawrence J. Wilson, Yesim A. Tahirovic, Polina Lyuboslavsky, David S. Menaldino, Zackery W. Dentmon, George W. Koszalka, Robert Zaczek, Raymond J. Dingledine, Stephen F. Traynelis, Dennis C. Liotta. A Glutamate N -Methyl-d-Aspartate (NMDA) Receptor Subunit 2B–Selective Inhibitor of NMDA Receptor Function with Enhanced Potency at Acidic pH and Oral Bioavailability for Clinical Use. Journal of Pharmacology and Experimental Therapeutics 2021, 379 (1) , 41-52. https://doi.org/10.1124/jpet.120.000370
12. Kasper B. Hansen, Lonnie P. Wollmuth, Derek Bowie, Hiro Furukawa, Frank S. Menniti, Alexander I. Sobolevsky, Geoffrey T. Swanson, Sharon A. Swanger, Ingo H. Greger, Terunaga Nakagawa, Chris J. McBain, Vasanthi Jayaraman, Chian-Ming Low, Mark L. Dell’Acqua, Jeffrey S. Diamond, Chad R. Camp, Riley E. Perszyk, Hongjie Yuan, Stephen F. Traynelis, . Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels. Pharmacological Reviews 2021, 73 (4) , 1469-1658. https://doi.org/10.1124/pharmrev.120.000131
13. Bing-Xue Li, Guang-Hui Dong, Hao-Long Li, Jia-Song Zhang, Yan-Hua Bing, Chun-Ping Chu, Song-Biao Cui, De-Lai Qiu. Chronic Ethanol Exposure Enhances Facial Stimulation-Evoked Mossy Fiber–Granule Cell Synaptic Transmission via GluN2A Receptors in the Mouse Cerebellar Cortex. Frontiers in Systems Neuroscience 2021, 15 https://doi.org/10.3389/fnsys.2021.657884
14. Hamada S. Abulkhair, Salwa Elmeligie, Adel Ghiaty, Ahmed El‐Morsy, Ashraf H. Bayoumi, Hany E. A. Ahmed, Khaled El‐Adl, Mohamed F. Zayed, Memy H. Hassan, Eman N. Akl, Mona S. El‐Zoghbi. In vivo‐ and in silico‐driven identification of novel synthetic quinoxalines as anticonvulsants and AMPA inhibitors. Archiv der Pharmazie 2021, 354 (5) https://doi.org/10.1002/ardp.202000449
15. Takeshi Fuchigami, Morio Nakayama, Yasuhiro Magata. Development of PET and SPECT Radioligands for In Vivo Imaging of NMDA Receptors. 2021, 661-711. https://doi.org/10.1007/978-3-030-53176-8_19
16. Wenwu Liu, Xiaowen Jiang, Yuxin Zu, Yue Yang, Yaqian Liu, Xue Sun, Zihua Xu, Huaiwei Ding, Qingchun Zhao. A comprehensive description of GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists. European Journal of Medicinal Chemistry 2020, 200 , 112447. https://doi.org/10.1016/j.ejmech.2020.112447
17. Nadezhda S. Temnyakova, Dmitry A. Vasilenko, Oleg I. Barygin, Mikhail Y. Dron, Elena B. Averina, Yuri K. Grishin, Vladimir V. Grigoriev, Vladimir A. Palyulin, Maxim V. Fedorov, Dmitry S. Karlov. Ifenprodil-like NMDA receptor modulator based on the biphenyl scaffold. Mendeleev Communications 2020, 30 (3) , 342-343. https://doi.org/10.1016/j.mencom.2020.05.027
18. Chao Ma, Baichun Hu, Linkui Zhang, Ying Zhao, Mingxing Wang, Jian Wang, Maosheng Cheng. Computational investigation of the antagonism effect towards GluN2B-Containing NMDA receptor: Combined ligand-based and target-based approach. Journal of Molecular Graphics and Modelling 2019, 86 , 95-105. https://doi.org/10.1016/j.jmgm.2018.10.009
19. Vishal P. Zambre, Varsha A. Hambarde, Nilesh N. Petkar, Chinmay N. Patel, Sanjay D. Sawant. Structural investigations by in silico modeling for designing NR2B subunit selective NMDA receptor antagonists. RSC Advances 2015, 5 (30) , 23922-23940. https://doi.org/10.1039/C5RA01098E
20. John Mitcheson, Annarosa Arcangeli. The Therapeutic Potential of hERG1 K+ Channels for Treating Cancer and Cardiac Arrhythmias. 2014, 258-296. https://doi.org/10.1039/9781849735087-00258
21. Derek J Leishman, Zoran Rankovic. Drug Discovery vs hERG. 2014, 225-259. https://doi.org/10.1007/7355_2014_38
22. Takeshi Fuchigami, Morio Nakayama, Yasuhiro Magata. Development of Radioligands for In Vivo Imaging of NMDA Receptors. 2014, 513-559. https://doi.org/10.1007/978-3-642-42014-6_18
23. Yadaganahalli K. Bommegowda, Gejjalagere S. Lingaraju, Saji Thamas, Koravangala S. Vinay Kumar, Challanayakanahally S. Pradeepa Kumara, Kanchugarakoppal S. Rangappa, Marilinganadoddi P. Sadashiva. Weinreb amide as an efficient reagent in the one pot synthesis of benzimidazoles and benzothiazoles. Tetrahedron Letters 2013, 54 (21) , 2693-2695. https://doi.org/10.1016/j.tetlet.2013.03.075
24. Martine Dhilly, Javier Becerril‐Ortega, Nathalie Colloc'h, Eric T. MacKenzie, Louisa Barré, Alain Buisson, Olivier Nicole, Cécile Perrio. Synthesis and in Vitro Characterisation of Ifenprodil‐Based Fluorescein Conjugates as GluN1/GluN2B N ‐Methyl‐ D ‐aspartate Receptor Antagonists. ChemBioChem 2013, 14 (6) , 759-769. https://doi.org/10.1002/cbic.201200675
25. Paula A. Abreu, Helena C. Castro, Roberto Paes‐de‐Carvalho, Carlos R. Rodrigues, Viveca Giongo, Izabel C. N. P. Paixão, Marcos V. Santana, Jainne M. Ferreira, Octavia M. Caversan, Raquel A. C. Leão, Luana M. S. Marins, André M. Henriques, Florence M. C. Farias, Magaly G. Albuquerque, Sergio Pinheiro. Molecular Modeling of a Phenyl‐Amidine Class of NMDA Receptor Antagonists and the Rational Design of New Triazolyl‐Amidine Derivatives. Chemical Biology & Drug Design 2013, 81 (2) , 185-197. https://doi.org/10.1111/cbdd.12056
26. Matilda Bingham, Zoran Rankovic. Medicinal Chemistry Challenges in CNS Drug Discovery. 2012, 465-509. https://doi.org/10.1039/9781849734943-00465
27. Pieter B. Burger, Hongjie Yuan, Erkan Karakas, Matthew Geballe, Hiro Furukawa, Dennis C. Liotta, James P. Snyder, Stephen F. Traynelis. Mapping the Binding of GluN2B-Selective N -Methyl-d-aspartate Receptor Negative Allosteric Modulators. Molecular Pharmacology 2012, 82 (2) , 344-359. https://doi.org/10.1124/mol.112.078568
28. Romain Labas, Gwénaëlle Gilbert, Olivier Nicole, Martine Dhilly, Ahmed Abbas, Olivier Tirel, Alain Buisson, Joël Henry, Louisa Barré, Danièle Debruyne, Franck Sobrio. Synthesis, evaluation and metabolic studies of radiotracers containing a 4-(4-[18F]-fluorobenzyl)piperidin-1-yl moiety for the PET imaging of NR2B NMDA receptors. European Journal of Medicinal Chemistry 2011, 46 (6) , 2295-2309. https://doi.org/10.1016/j.ejmech.2011.03.013
29. Shahnaz Rostamizadeh, Reza Aryan, Hamid Reza Ghaieni. Aqueous 1 M Glucose Solution as a Novel and Fully Green Reaction Medium and Catalyst for the Oxidant-Free Synthesis of 2-Arylbenzimidazoles. Synthetic Communications 2011, 41 (12) , 1794-1804. https://doi.org/10.1080/00397911.2010.492460
30. Marco Martín González-Chávez, Francisco Méndez, Roberto Martínez, Cuaúhtemoc Pérez-González, Fidel Martínez-Gutiérrez. Design and Synthesis of Anti-MRSA Benzimidazolylbenzene-sulfonamides. QSAR Studies for Prediction of Antibacterial Activity. Molecules 2011, 16 (1) , 175-189. https://doi.org/10.3390/molecules16010175
31. Takeshi Fuchigami, Hiroshi Yamaguchi, Mikako Ogawa, Le Biao, Morio Nakayama, Mamoru Haratake, Yasuhiro Magata. Synthesis and biological evaluation of radio-iodinated benzimidazoles as SPECT imaging agents for NR2B subtype of NMDA receptor. Bioorganic & Medicinal Chemistry 2010, 18 (21) , 7497-7506. https://doi.org/10.1016/j.bmc.2010.08.053
32. Kasper B. Hansen, Hiro Furukawa, Stephen F. Traynelis. Control of Assembly and Function of Glutamate Receptors by the Amino-Terminal Domain. Molecular Pharmacology 2010, 78 (4) , 535-549. https://doi.org/10.1124/mol.110.067157
33. Philippe G. Nantermet, Evan F. Shalen, Shankar Venkatraman, Hong Zhu, Robert J. Mark. Stroke Therapy. 2010, 447-828. https://doi.org/10.1002/0471266949.bmc250
34. Stephen F. Traynelis, Lonnie P. Wollmuth, Chris J. McBain, Frank S. Menniti, Katie M. Vance, Kevin K. Ogden, Kasper B. Hansen, Hongjie Yuan, Scott J. Myers, Ray Dingledine, . Glutamate Receptor Ion Channels: Structure, Regulation, and Function. Pharmacological Reviews 2010, 62 (3) , 405-496. https://doi.org/10.1124/pr.109.002451
35. X‐K Wee, K‐S Ng, H‐W Leung, Y‐P Cheong, K‐H Kong, F‐M Ng, W Soh, Y Lam, C‐M Low. Mapping the high‐affinity binding domain of 5‐substituted benzimidazoles to the proximal N‐terminus of the GluN2B subunit of the NMDA receptor. British Journal of Pharmacology 2010, 159 (2) , 449-461. https://doi.org/10.1111/j.1476-5381.2009.00549.x
36. Shagufta, Dong Guo, Elisabeth Klaasse, Henk de Vries, Johannes Brussee, Lukáš Nalos, Martin B. Rook, Marc A. Vos, Marcel A. G. van der Heyden, Adriaan P. IJzerman. Exploring Chemical Substructures Essential for hERG K + Channel Blockade by Synthesis and Biological Evaluation of Dofetilide Analogues. ChemMedChem 2009, 4 (10) , 1722-1732. https://doi.org/10.1002/cmdc.200900203
37. Alba Chimirri, Laura De Luca, Stefania Ferro, Giovanbattista De Sarro, Lucia Ciranna, Rosaria Gitto. Combined Strategies for the Discovery of Ionotropic Glutamate Receptor Antagonists. ChemMedChem 2009, 4 (6) , 917-922. https://doi.org/10.1002/cmdc.200900109
38. Rosaria Gitto, Laura De Luca, Stefania Ferro, Rita Citraro, Giovambattista De Sarro, Lara Costa, Lucia Ciranna, Alba Chimirri. Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists. Bioorganic & Medicinal Chemistry 2009, 17 (4) , 1640-1647. https://doi.org/10.1016/j.bmc.2008.12.058
39. Sitarama B. Gunturi, Kotu Archana, Akash Khandelwal, Ramamurthi Narayanan. Prediction of hERG Potassium Channel Blockade Using kNN‐QSAR and Local Lazy Regression Methods. QSAR & Combinatorial Science 2008, 27 (11-12) , 1305-1317. https://doi.org/10.1002/qsar.200810072
40. Fui-Mee Ng, Matthew T Geballe, James P Snyder, Stephen F Traynelis, Chian-Ming Low. Structural insights into phenylethanolamines high-affinity binding site in NR2B from binding and molecular modeling studies. Molecular Brain 2008, 1 (1) https://doi.org/10.1186/1756-6606-1-16
41. Cai Xiao, Yuanyuan Huang, Mingxin Dong, Jie Hu, Shuangshuang Hou, Francis J. Castellino, Mary Prorok, Qiuyun Dai. NR2B-selective conantokin peptide inhibitors of the NMDA receptor display enhanced antinociceptive properties compared to non-selective conantokins. Neuropeptides 2008, 42 (5-6) , 601-609. https://doi.org/10.1016/j.npep.2008.09.003
42. Craig Jamieson, Elizabeth M. Moir, Zoran Rankovic, Grant Wishart. Strategy and Tactics for hERG Optimizations. 2008, 423-455. https://doi.org/10.1002/9783527621460.ch18
43. V. V. Elkin, L. N. Tolkacheva, N. B. Chernysheva, I. B. Karmanova, L. D. Konyushkin, V. V. Semenov. Hydrogenation on palladium-containing granulated catalysts 3. Synthesis of aminobenzimidazoles by catalytic hydrogenation of dinitroanilines. Russian Chemical Bulletin 2007, 56 (6) , 1216-1226. https://doi.org/10.1007/s11172-007-0184-z
44. David Bleakman, Andrew Alt, David Lodge, Daniel T. Monaghan, David E. Jane, Eric S. Nisenbaum. Ionotropic Glutamate Receptors. 2007https://doi.org/10.1002/9780470101001.hcn010
45. A.M. Aronov. In Silico Models to Predict QT Prolongation. 2007, 933-955. https://doi.org/10.1016/B0-08-045044-X/00156-5
46. István Borza, Sándor Kolok, Anikó Gere, József Nagy, László Fodor, Kornél Galgóczy, József Fetter, Ferenc Bertha, Béla Ágai, Csilla Horváth, Sándor Farkas, György Domány. Benzimidazole-2-carboxamides as novel NR2B selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2006, 16 (17) , 4638-4640. https://doi.org/10.1016/j.bmcl.2006.06.002
47. John A McCauley. Amide-containing NR2B/NMDA receptor antagonists. Expert Opinion on Therapeutic Patents 2006, 16 (6) , 863-870. https://doi.org/10.1517/13543776.16.6.863
48. Laszlo Kiss, Gong Cheng, Bohumil Bednar, Rodney A. Bednar, Paul B. Bennett, Stefanie A. Kane, Charles J. McIntyre, John A. McCauley, Kenneth S. Koblan. In vitro characterization of novel NR2B selective NMDA receptor antagonists. Neurochemistry International 2005, 46 (6) , 453-464. https://doi.org/10.1016/j.neuint.2004.12.008
49. James N. C. Kew, John A. Kemp. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology 2005, 179 (1) , 4-29. https://doi.org/10.1007/s00213-005-2200-z
50. John A McCauley. NR2B subtype-selective NMDA receptor antagonists: 2001 – 2004. Expert Opinion on Therapeutic Patents 2005, 15 (4) , 389-407. https://doi.org/10.1517/13543776.15.4.389